(BUSINESS WIRE)-- KFx Medical Corporation, an emerging leader in soft tissue disease repair and bone implant products, today announced a third new patent grant. The new patent (U.S. Patent No. 8,109,969 designated for knotless double row soft tissue to bone repair method) was secured in only 4 months via participation in the USPTO Patent Accelerated Examination Program.
Today's announcement highlights KFx Medical's ongoing commitment to driving innovation in the orthopedic and medical devices industry. In January, KFx Medical was awarded U.S. Patent No. 8,100,942 also broadly covering knotless double row rotator cuff repair. The company now has three issued patents covering that method of rotator cuff repair.
"KFx Medical makes tendon repair easier and more secure. Through technologies such as AppianFx, our goal is to provide a new standard of care in an area marked previously with a wide variety of techniques and products," indicated Tate Scott, KFx Medical president and CEO. "Surgeons want a single, dependable, and reproducible system for their patients' shoulders, knees and other areas where tissue is reattached to bone."
In 2011, KFx Medical's first and seminal patent in double row knotless fixation survived an attack by an anonymous third party seeking to overturn the patent. The patent office rejected all arguments made by the anonymous party and completely upheld the KFx patent. KFx is represented by Knobbe Martens for its patent matters.